Although insulin stimulates osteogenic proliferation, differentiation and bone formation via insulin growth factor (IGF) receptor binding and downstream signalling pathway activation [61], such responses differ in T2DM due to insulin resistance and absence of IGF receptor stimulation. The gene discussed is INS; the disease is type 2 diabetes mellitus.